0      0

KN10 - Expanding Globally While Achieving Net Zero

‐ Jan 30, 2024 3:25pm

Moderna’s mRNA platform allows for many different therapies to be made using the same equipment having a small environmental footprint compared to traditional biologics manufacturing. We are undergoing a global expansion, building new manufacturing facilities in Massachusetts, Laval Quebec, Canada, Harwell, UK, Victoria Australia and new R&D laboratory and corporate headquarters in Cambridge, MA. Building out this manufacturing network had to be done with net-zero in mind in order to meet our net zero scope 1 & 2 by 2030 commitment. This presentation will highlight the design elements put into place to fulfill this goal.